Welcome to Medications.com

Advair Diskus News

FDA Advisory Committee Finds Substantial Evidence to Support ... - Pharmaceutical Processing

An Advisory Committee to the FDA recently unanimously agreed (11 to 0) that GlaxoSmithKline's Advair DiskusĀ® 500/50 (fluticasone propionate and salmeterol ...

http://www.pharmpro.com/ShowPR~PU... | Posted: Wed May 09 06:36:57 -0400 2007

FDA Advisory Committee Finds Substantial Evidence To Support ... - Medical News Today (press release)

An Advisory Committee to the US Food and Drug Administration (FDA) today unanimously agreed (11 to 0) that GlaxoSmithKline's Advair DiskusĀ® 500/50 ...

http://www.medicalnewstoday.com/m... | Posted: Tue May 08 00:13:54 -0400 2007

Doctors Say Treating Condition Requires the Right Medicine and the ... - LA Downtown News Online

In 2005, the Food and Drug Administration requested the manufacturers of Advair diskus, Foradil Aerolizer and Servent diskus update their product labels ...

http://www.ladowntownnews.com/art... | Posted: Mon Apr 16 04:13:35 -0400 2007

GlaxoSmithKline wins Japanese approval for bronchial asthma treatment - International Herald Tribune

LONDON: GlaxoSmithKline PLC said Wednesday it received approval for its Seretide/Advair Diskus and Arixtra bronchial asthma treatment in Japan. ...

http://www.iht.com/articles/ap/20... | Posted: Wed Apr 18 07:33:24 -0400 2007

Glaxo gets marketing OK for Advair and Arixtra in Japan - Forbes

Seretide/Advair will be branded Advair Diskus, and has been approved for adult patients with bronchial asthma. Glaxo said it will be the only combination ...

http://www.forbes.com/business/fe... | Posted: Wed Apr 18 00:52:05 -0400 2007

GlaxoSmithKline: Advair, Arixtra Receive Approval In Japan - Therapeutics Daily (subscription) (press release)

LONDON (Dow Jones)--GlaxoSmithKline Wednesday announced that it has received approval for Seretide/Advair Diskus and Arixtra from the Ministry of Health, ...

http://www.therapeuticsdaily.com/... | Posted: Wed Apr 18 04:17:47 -0400 2007

Japanese nod for GSK's Seretide/Advair and Arixtra - Pharma Times (subscription)

GlaxoSmithKline has received approval in Japan for its key respiratory product Seretide/Advair Diskus and its anti-thrombotic Arixtra, a move which the ...

http://www.pharmatimes.com/WorldN... | Posted: Thu Apr 19 02:26:14 -0400 2007

GlaxoSmithKline Receives Japanese Approval For Two Major New ... - Medical News Today (press release)

GlaxoSmithKline (GSK) today announced that it has received approval for Seretide/Advair Diskus (salmeterol and fluticasone proprionate combination) and ...

http://www.medicalnewstoday.com/m... | Posted: Mon Apr 23 00:03:24 -0400 2007

FDA panel not sure GSK's Advair increases COPD survival - Pharma Times (subscription)

... view that the highest dose of its asthma blockbuster Advair Diskus can increase survival rates for patients with chronic obstructive pulmonary disease. ...

http://www.pharmatimes.com/WorldN... | Posted: Wed May 02 02:54:26 -0400 2007

FDA Advisory Committee Finds Substantial Evidence to Support ... - Compliance Home

(May 1, 2007)-- An Advisory Committee to the US Food and Drug Administration (FDA) unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus(R) ...

http://compliancehome.com/news/FD... | Posted: Wed May 02 08:52:42 -0400 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea